Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimu (V5) (IMM05)

Clinical Trial ID NCT02232490

PubWeight™ 2.50^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02232490

Top papers